Concepedia

John P. Fruehauf

JP

Statistics

Publications

58

Citations

3.5K

H-Index

35

Active since

1982

Affiliations

University of California, Irvine(Current)

University of California, Irvine Medical Center

Atotech (United States)

Gynecologic Oncology Group

National Cancer Institute

John P. Fruehauf is an author at University of California, Irvine specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

1982–2021

58

Publications

58

Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin.

Eugene Mechetner, Ainura Kyshtoobayeva, Svetlana Zonis et al. · PubMed · 1998 · 291 citations

, , +18

BEAM: A Randomized Phase II Study Evaluating the Activity of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Melanoma

Kevin B. Kim, Jeffrey A. Sosman, John P. Fruehauf et al. · Journal of Clinical Oncology · 2011 · 196 citations · Full text

Diastolic Blood Pressure as a Biomarker of Axitinib Efficacy in Solid Tumors

Brian I. Rini, Joan H. Schiller, John P. Fruehauf et al. · Clinical Cancer Research · 2011 · 179 citations · Full text

Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer

Min‐Ying Su, Yun‐Chung Cheung, John P. Fruehauf et al. · Journal of Magnetic Resonance Imaging · 2003 · 153 citations

Prediction of Drug Response in Breast Cancer Using Integrative Experimental/Computational Modeling

Hermann B. Frieboes, Mary E. Edgerton, John P. Fruehauf et al. · Cancer Research · 2009 · 143 citations · Full text

, , +19

1–5 of 58